ShiLai™ Healthcare — Peptide Manufacturer & Retatrutide OEM

Third-Party Analytical Testing

Retatrutide Janoshik Test & Purity Analysis

Janoshik testing provides independent third-party analytical verification of peptide purity and identity. This page explains what a Retatrutide Janoshik test report contains, how it is used in B2B procurement, and how it relates to manufacturer batch documentation.

Request Batch Documentation

What Is a Retatrutide Janoshik Test?

Janoshik is an independent analytical laboratory that accepts peptide samples submitted by buyers, distributors, and researchers for third-party testing. A Janoshik test report is produced by the laboratory from a sample submitted externally — it is not issued by the manufacturer.

For Retatrutide, a Janoshik test typically involves reversed-phase HPLC purity analysis and, in some cases, mass spectrometry identity confirmation. The result is a publicly accessible or privately shared report that documents the analytical findings for that specific sample.

Third-party testing of this kind is used by buyers who wish to independently verify the purity and identity of a peptide batch before or after purchase, separate from the documentation provided by the manufacturer.

Retatrutide Purity Analysis

Purity analysis for Retatrutide is performed by reversed-phase high-performance liquid chromatography (RP-HPLC). The chromatographic separation produces a purity percentage that reflects the proportion of the target peptide relative to all detected components in the sample.

A purity result from an independent laboratory reflects the condition of the specific sample submitted — which may differ from the original batch depending on handling, storage, and shipping conditions between manufacture and testing.

ShiLai™ Healthcare performs in-house HPLC purity testing on every batch prior to shipment. The purity result is documented in the Certificate of Analysis (COA) issued at the point of batch release.

What a Janoshik Test Report Can Show

A Janoshik test report typically documents the following fields for the submitted sample:

Sample identification

The sample reference or identifier as submitted by the requester.

Analytical method

The method used — typically RP-HPLC for purity, LC-MS or HRMS for identity confirmation.

Purity result

The percentage purity of the target peptide as measured from the submitted sample.

Chromatogram

The HPLC chromatographic trace showing peak separation and relative peak areas.

Test date

The date on which the analysis was performed at the laboratory.

Laboratory reference

The Janoshik report reference number for the specific test.

Janoshik reports document the sample as received. They do not certify the manufacturing process, batch history, or storage conditions prior to submission.

Janoshik Test vs COA

A Janoshik test report and a manufacturer Certificate of Analysis (COA) serve different documentation roles and are not interchangeable.

A manufacturer COA is issued by the producing laboratory at the point of batch release. It documents the analytical results for the full batch as manufactured — including purity, identity, appearance, and any other release specifications — and accompanies the batch from manufacture to shipment.

A Janoshik test report documents the analytical findings for a specific sample submitted to an independent laboratory after manufacture. It provides a buyer-initiated verification of the sample condition at the time of testing.

Both documents can be relevant in B2B procurement: the COA establishes the manufacturer's release specification; a third-party test provides independent verification of a specific sample.

Batch Quality Documentation

ShiLai™ Healthcare supports B2B partners with a complete set of batch documentation at the point of shipment. This includes the Certificate of Analysis, HPLC chromatogram, LC-MS identity data, and batch release records.

Batch documentation is issued per batch and is traceable to the specific manufacturing run. Partners requiring additional analytical documentation or third-party testing coordination should contact ShiLai™ Healthcare directly.

Frequently Asked Questions

Can I request a Janoshik test on a ShiLai™ Healthcare Retatrutide batch?

Yes. Buyers may submit a sample from their received batch to Janoshik or any independent analytical laboratory of their choice. ShiLai™ Healthcare supports third-party verification and provides the manufacturer COA for cross-reference.

What purity does ShiLai™ Healthcare specify for Retatrutide?

ShiLai™ Healthcare specifies ≥98% purity by RP-HPLC for Retatrutide batches. The purity result for each batch is documented in the Certificate of Analysis issued at batch release.

Does a Janoshik test replace the manufacturer COA?

No. A Janoshik test report documents the condition of a specific submitted sample. The manufacturer COA documents the full batch as released from the manufacturing facility. Both serve distinct documentation roles.

How do I obtain batch documentation for a ShiLai™ Healthcare order?

Batch documentation including the COA, HPLC chromatogram, and LC-MS data is provided with every shipment. Contact ShiLai™ Healthcare via WhatsApp to request documentation for a specific batch.

Request Batch Documentation

Contact ShiLai™ Healthcare to request the COA, HPLC chromatogram, and LC-MS data for your batch.

Chat on WhatsApp